GSBR-5595 / Structure Therap - LARVOL DELTA

Structure Therapeutics Announces…Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions… (GlobeNewswire) - "Structure Therapeutics...announced...upcoming late-breaking poster presentations at the American Diabetes Association 85th Scientific Sessions....In a Parkinson’s disease mouse model, oral administration of GSBR-5595...significantly improved motor coordination and movement in both the rotarod and open field tests. Additionally, histopathological analyses revealed a significant increase in dopaminergic neurons."

Late-breaking abstract • Preclinical • Parkinson's Disease